MCKESSON CORP (MCK)

765.04 -0.13 (-0.02%)

As of 2026-05-22 14:59:46 EST

McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK".

Traded asNYSE: MCK
ISINUS58155Q1031
CIK0000927653
LEI549300WZWOM80UCFSF54
EIN943207296
SectorHealthcare
IndustryWholesale-Drugs, Proprietaries & Druggists' Sundries
CEOBrian S. Tyler
Employees45,000
Fiscal Year End0331
Address6555 STATE HIGHWAY 161, IRVING, TX, 75039
Phone972-446-4800
Websitehttp://mckesson.com
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
MCKMCKESSON CORP2026-05-22 14:59:46765.04-0.13-0.02
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
MCK0000927653MCKESSON CORPUS58155Q1031549300WZWOM80UCFSF54943207296NYSE5122Wholesale-Drugs, Proprietaries & Druggists' Sundries0331DE6555 STATE HIGHWAY 161IRVINGTX75039UNITED STATESUS972-446-48006555 STATE HIGHWAY 161, IRVING, TX, 750396555 STATE HIGHWAY 161, IRVING, TX, 75039MCKESSON HBOC INCHealthcare1833Brian S. Tyler45,000http://mckesson.com95,300,000,000280,000,000120,204,051McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK".2026-05-21 15:15:01
This is a preview of the latest data. Subscribe to access the full data.
MCK Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
MCK Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
202695,300,000,00032,600,000,00051.9936120,204,051-4,908,185-3.923
202562,700,000,0004,900,000,0008.4775125,112,236-4,873,278-3.7491
202457,800,000,0009,600,000,00019.917129,985,514-5,616,748-4.1421
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Michele LauChief Legal Officer, Executive Vice President2025720,41703,001,093857,296647,8995,226,705
Leann B. SmithExecutive Vice President2025658,75002,200,981783,91374,2553,717,899
Brian S. TylerChief Executive Officer20251,541,667014,500,5123,669,167450,36820,161,714
Britt J. Vitaloneexecutive VicePresident20251,025,00005,000,8531,524,688131,6407,682,181
Thomas L. RodgersExecutive Vice President2025631,11701,751,295751,02979,8663,213,307
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
202643,000
202545,000
202451,000
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202620252024
Revenue403,430,000,000359,051,000,000308,951,000,000
Cost Of Revenue388,880,000,000345,728,000,000296,123,000,000
Gross Profit14,550,000,00013,323,000,00012,828,000,000
Research And Development Expenses———
General And Administrative Expenses8,096,000,0008,507,000,0008,657,000,000
Operating Expenses8,338,000,0008,901,000,0008,919,000,000
Operating Income6,212,000,0004,422,000,0003,909,000,000
Net Income4,762,000,0003,295,000,0003,002,000,000
Earnings Per Share Basic38.5525.8622.54
Earnings Per Share Diluted38.3825.7222.39
Weighted Average Shares Outstanding Basic123,600,000127,400,000133,200,000
Weighted Average Shares Outstanding Diluted124,100,000128,100,000134,100,000
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202620252024
Cash And Cash Equivalents3,975,000,0005,691,000,0004,583,000,000
Marketable Securities Current———
Accounts Receivable27,985,000,00025,643,000,00021,622,000,000
Inventories24,207,000,00023,001,000,00021,139,000,000
Non Trade Receivables———
Other Assets Current1,043,000,0001,063,000,000626,000,000
Total Assets Current57,210,000,00055,398,000,00047,970,000,000
Marketable Securities Non Current———
Property Plant And Equipment2,668,000,0002,502,000,0002,316,000,000
Other Assets Non Current4,992,000,0003,972,000,0003,186,000,000
Total Assets Non Current25,113,000,00019,742,000,00019,473,000,000
Total Assets82,323,000,00075,140,000,00067,443,000,000
Accounts Payable59,973,000,00055,330,000,00047,097,000,000
Deferred Revenue———
Short Term Debt1,267,000,0001,191,000,00050,000,000
Other Liabilities Current5,490,000,0004,825,000,0004,915,000,000
Total Liabilities Current67,017,000,00061,604,000,00052,357,000,000
Long Term Debt6,526,000,0005,654,000,0005,629,000,000
Other Liabilities Non Current2,659,000,0002,659,000,0002,610,000,000
Total Liabilities Non Current-66,730,000,000-61,557,000,000-52,316,000,000
Total Liabilities287,000,00047,000,00041,000,000
Common Stock3,000,0003,000,0003,000,000
Retained Earnings22,291,000,00017,921,000,00014,978,000,000
Accumulated Other Comprehensive Income-745,000,000-932,000,000-881,000,000
Total Shareholders Equity-2,172,000,000-2,074,000,000-1,971,000,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202620252024
Depreciation And Amortization473,000,000394,000,000382,000,000
Share Based Compensation Expense175,000,000141,000,000110,000,000
Other Non Cash Income Expense-302,000,000-424,000,000-233,000,000
Change In Accounts Receivable1,999,000,0003,935,000,0002,954,000,000
Change In Inventories1,082,000,0002,270,000,0001,294,000,000
Change In Non Trade Receivables———
Change In Other Assets———
Change In Accounts Payable4,317,000,0008,301,000,0004,587,000,000
Change In Other Liabilities-219,000,000281,000,000-37,000,000
Cash From Operating Activities6,155,000,0006,085,000,0004,314,000,000
Purchases Of Marketable Securities———
Sales Of Marketable Securities———
Acquisition Of Property Plant And Equipment436,000,000859,000,000687,000,000
Acquisition Of Business3,416,000,00024,000,000272,000,000
Other Investing Activities101,000,00029,000,000160,000,000
Cash From Investing Activities-3,432,000,000-733,000,000-1,072,000,000
Tax Withholding For Share Based Compensation———
Payments Of Dividends393,000,000352,000,000320,000,000
Issuance Of Common Stock89,000,000101,000,000116,000,000
Repurchase Of Common Stock4,790,000,0003,172,000,0003,023,000,000
Issuance Of Long Term Debt1,990,000,000498,000,000991,000,000
Repayment Of Long Term Debt1,207,000,000519,000,000288,000,000
Other Financing Activities-372,000,000-554,000,000-175,000,000
Cash From Financing Activities-4,631,000,000-3,965,000,000-3,342,000,000
Change In Cash-1,888,000,0001,371,000,000-94,000,000
Cash At End Of Period3,975,000,0005,691,000,0004,583,000,000
Income Taxes Paid1,211,000,0001,124,000,000901,000,000
Interest Paid212,000,000273,000,000234,000,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202620252024
Earnings Per Share38.5525.8622.54
Price To Earnings Ratio22.447726.024423.8017
Earnings Growth Rate49.071914.7294-10.6619
Price Earnings To Growth Ratio0.45741.7668-2.2324
Book Value Per Share663.7217589.427506.021
Price To Book Ratio1.30381.14181.0602
Ebitda6,693,000,0005,078,000,0004,537,000,000
Enterprise Value110,776,496,00086,892,926,00072,556,468,000
Dividend Yield0.00370.00410.0045
Dividend Payout Ratio0.08250.10680.1066
Debt To Equity Ratio-3.5879-3.3004-2.8813
Capital Expenditures639,000,000580,000,000521,000,000
Free Cash Flow5,516,000,0005,505,000,0003,793,000,000
Return On Equity-2.1924-1.5887-1.5231
One Year Beta0.15850.0586-0.0181
Three Year Beta0.09710.25770.3683
Five Year Beta0.27490.49190.7207
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
TYLER BRIAN S.Director, Chief Executive Officer2026-05-203,189A24,127
TYLER BRIAN S.Director, Chief Executive Officer2026-05-201,282D22,845
TYLER BRIAN S.Director, Chief Executive Officer2026-05-203,189D6,378
Vitalone Britt J.EVP & CFO2026-05-201,038A20,707
Vitalone Britt J.EVP & CFO2026-05-20409D20,298
This is a preview of the latest data. Subscribe to access the full data.
Senate Trading
Name Of Reporting PersonType Of Reporting PersonReport DateTransaction TypeTransaction DateOwner TypeAmount
Markwayne MullinSenator2026-03-02Purchase2026-02-04Joint$15,001 - $50,000
Markwayne MullinSenator2026-02-04Purchase2026-01-05Self$15,001 - $50,000
Markwayne MullinSenator2026-02-04Purchase2026-01-05Spouse$15,001 - $50,000
Sheldon WhitehouseSenator2017-10-12Sale (Full)2017-09-20Joint$15,001 - $50,000
Sheldon WhitehouseSenator2017-03-15Purchase2017-02-23Joint$1,001 - $15,000
This is a preview of the latest data. Subscribe to access the full data.
House Trading
Name Of Reporting PersonReport DateStateTransaction TypeTransaction DateOwner TypeAmount
Elizabeth Fletcher2026-05-01TX07Sale (Partial)2026-04-08—$1,001 - $15,000
Jared Moskowitz2026-01-16FL23Purchase2025-12-02Child$1,001 - $15,000
Jared Moskowitz2026-01-16FL23Purchase2025-12-02—$1,001 - $15,000
Julia Letlow2026-01-13LA05Purchase2024-12-18—$1,001 - $15,000
Gilbert Cisneros2026-01-12CA31Sale2025-12-19—$1,001 - $15,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
SEGALL BRYANT & HAMILL, LLC2026-03-3147,175,20454,515865.3619
GROUPAMA ASSET MANAGMENT2026-03-312,240,4172,589865.36
VERUS CAPITAL PARTNERS, LLC2026-03-31252,685292865.3596
Access Investment Management LLC2026-03-3147,59555865.3636
JDM Financial Group LLC2026-03-3121,63425865.36
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
BUFFALO FUNDS2026-03-31Institutional ClassBUIDX2,5002,163,4001.2975
BUFFALO FUNDS2026-03-31Investor ClassBUFDX2,5002,163,4001.2975
iSHARES TRUST2026-03-31iShares Global Healthcare ETFIXJ58,92850,993,934.081.4071
iSHARES TRUST2026-03-31iShares Russell 1000 Value ETFIWD22,27019,271,567.20.0276
iSHARES TRUST2026-03-31iShares Texas Equity ETFTEXN374323,644.642.0446
This is a preview of the latest data. Subscribe to access the full data.